Why Fewer Clinical Trials in Africa is Bad for Innovation

"The African continent offers many of the best conditions for conducting clinical trials. It has a diverse population of potential patients, and many have not been previously exposed to any kind of pharmaceutical drugs ... So it makes sense to run clinical trials for drugs that would treat diseases endemic to the developing world in the areas most affected by them," writes Swapan Kumar Patra for The Conversation.

Photo: Pexels

(file photo).

See What Everyone is Watching

Don't Miss

AllAfrica publishes around 600 reports a day from more than 150 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.